**Core tip:** Pancreaticoduodenectomy remains the standard surgical approach for tumors involving the lower bile duct, the pancreatic head, the duodenal papilla, and the ampulla. This operation is considered risky because of high rates of postoperative mortality and complications. In this study, we collected a large sample of 539 cases and analyzed several potential risk factors for pancreatic fistula. A statistical analysis of the case data showed that gender (male), pancreatic duct-jejunum double-layer mucosa-to-mucosa pancreaticojejunal anastomosis, pancreatic duct diameter ≤ 3 mm, and soft pancreas were risk factors for pancreatic fistula after pancreaticoduodenectomy.

INTRODUCTION
============

Pancreaticoduodenectomy is the primary treatment for malignant tumors involving the pancreatic head, the lower bile duct, and the duodenal ampulla\[[@B1],[@B2]\]. The safety of pancreaticoduodenectomy has been greatly improved; however, perioperative mortality rate still ranges from 0%-5%\[[@B3]-[@B5]\]. Studies have reported that the incidence of pancreatic fistula after pancreaticoduodenectomy is approximately 11.4%-64.3%\[[@B6]-[@B16]\]. Pancreatic fistula remains the most common complication after pancreaticoduodenectomy, and this complication prolongs hospital stays and leads to high medical expenses. Pancreatic fistula is associated with delayed gastric emptying, abdominal abscesses, infection at the incision, sepsis, and bleeding after pancreaticoduodenectomy\[[@B17]-[@B20]\]. Several approaches may reduce the incidence of pancreatic fistula after pancreaticoduodenectomy; however, to date, a definitive approach that prevents pancreatic fistula is still lacking\[[@B21]-[@B23]\]. In this study, we conducted a retrospective analysis of 539 successive cases of pancreaticoduodenectomy performed over more than 3 years in the Department of Hepatobiliary Surgery of the PLA General Hospital, China, to determine the potential risk factors for pancreatic fistula.

MATERIALS AND METHODS
=====================

Patients and data collection
----------------------------

We reviewed the data from 539 successive cases of pancreaticoduodenectomy performed in the Department of Hepatobiliary Surgery of the PLA General Hospital, China, from March 2012 to October 2015. The following patient data were collected: gender, age, hypertension, diabetes, alcohol consumption, smoking, body mass index (BMI), history of upper abdominal surgery, preoperative jaundice management, blood sugar, preoperative bilirubin, preoperative albumin, pancreatic duct drainage, intraoperative blood loss, intraoperative blood transfusion, operative time, pancreaticojejunal anastomosis technique, Braun anastomosis, pylorus preservation, diameter of the pancreatic duct, and pancreatic texture. Additionally, all postoperative complications and postoperative pathological findings (especially information about pancreatic fistula) were recorded. All 539 cases were included in this comprehensive study.

Preoperative preparation
------------------------

Prior to surgery, the patients underwent routine tests, examinations, and evaluations of organ function. To date, no uniform standard exists for preoperative jaundice management. We believe that patients with obstructive jaundice who have a poor mental state, severe dehydration, poor nutrition, or severe jaundice should undergo jaundice management and supportive therapy to improve their nutritional intake and replenish fluids. Patients should subsequently undergo surgery after their general condition has improved.

Surgical approach
-----------------

In this study, 275 patients underwent classic pancreaticoduodenectomy, of whom 13 had portal vein resection and reconstruction. Additionally, 264 patients underwent pylorus-preserving pancreaticoduodenectomy, of whom six had portal vein resection and reconstruction. Child's technique (pancreaticojejunal anastomosis, biliary-jejunal anastomosis, and gastrojejunal anastomosis in sequential order) was used for the gastrointestinal reconstruction. A support tube was placed in the pancreatic duct of all patients. The support tube was drained *via* the jejunal loop to outside the body in 127 patients. In the remaining patients, the tube was placed in the jejunum *via* biliary-jejunal anastomosis. The following two approaches were used for pancreaticojejunal anastomosis: (1) pancreatic duct-jejunum double-layer mucosa-to-mucosa pancreaticojejunal anastomosis in 398 patients; and (2) pancreatic-jejunum single-layer mucosa-to-mucosa anastomosis in 141 patients.

Classification and detailed definition of postoperative pancreatic fistula
--------------------------------------------------------------------------

Pancreatic fistula was defined according to the International Study Group on Pancreatic Fistula (ISGPF) as any measurable volume of drainage fluid output *via* operatively or postoperatively placed drains on or after postoperative day 3 with amylase content greater than three times the upper normal serum value. Three grades of pancreatic fistulas were determined according to their clinical severity. The grades were determined only after complete healing of the fistula (Table [1](#T1){ref-type="table"})\[[@B24]\].

###### 

Criteria utilized to grade postoperative pancreatic fistula

  Grade                                                              A          B                   C
  ------------------------------------------------------------------ ---------- ------------------- -------------------
  Clinical conditions                                                Well       Often well          Ill appearing/bad
  Specific treatment[1](#T1FN1){ref-type="table-fn"}                 No         Yes/no              Yes
  US/CT (if obtained)                                                Negative   Negative/positive   Positive
  Persistent drainage (after 3 wk)[2](#T1FN2){ref-type="table-fn"}   No         Usually yes         Yes
  Reoperation                                                        No         No                  Yes
  Death related to POPF                                              No         No                  Possibly yes
  Signs of infection                                                 No         Yes                 Yes
  Sepsis                                                             No         No                  Yes
  Readmission                                                        No         Yes/no              Yes/no

Partial (peripheral) or total parenteral nutrition, antibiotics, enteral nutrition, somatostatin analogue, and/or minimally invasive drainage;

With or without a drain *in situ*. CT: Computed tomography; POPF: Postoperative pancreatic fistula; US: Ultrasonography.

Statistical analysis
--------------------

All clinical data were entered into an Excel spreadsheet, and SPSS 19.0 software was used for statistical analyses. Measurement data are expressed as the mean ± SD. A *t*-test was performed for between-group comparisons. Categorical variables were analyzed using Fisher's exact test and the χ^2^ test. All variables were incorporated into a univariate analysis. *P* \< 0.05 was considered statistically significant. Statistically significant variables demonstrated in the univariate analysis were incorporated into a multivariate logistic regression analysis to identify the independent risk factors for pancreatic fistula after pancreaticoduodenectomy.

RESULTS
=======

Overall characteristics of patients and complications
-----------------------------------------------------

This study included 343 male patients and 196 female patients with a mean age of 56.42 ± 10.75 years. The mean hospital stay was 30.03 ± 8.86 d. The condition (confirmed by postoperative pathology) of the 539 patients is shown in Table [2](#T2){ref-type="table"}. Among the 539 patients, 349 (64.75%) experienced complications, and 269 (49.9%) had POPF, including 71 (13.17%) cases of grade A pancreatic fistula, 178 (33.02%) cases of grade B, and 20 (3.71%) cases of grade C. Additionally, 198 (36.73%) patients had clinically relevant POPFs. The following complications were identified: 25 (4.64%) cases of abdominal bleeding, 59 (10.95%) cases of bile leakage, 120 (22.63%) cases of delayed gastric emptying, 9 (1.67%) cases of pancreaticojejunal anastomotic bleeding, 66 (12.24%) cases of abdominal infection, and 45 (8.35%) cases of incision infection. Moreover, 15 (2.78%) patients underwent a second operation, and 6 (1.11%) patients died after surgery due to abdominal bleeding associated with a pancreatic fistula.

###### 

Disease composition

  Pathological type                                         *n*
  --------------------------------------------------------- -----
  Pancreatic head cancer                                    126
  Neuroendocrine tumor of the pancreatic head               12
  Benign tumor of the pancreatic head                       12
  Solid pseudopapillary tumor of the pancreatic head        16
  Autoimmune pancreatitis                                   3
  Chronic pancreatitis                                      11
  Lower bile duct cancer                                    145
  Benign tumor of the lower bile duct                       13
  Ampullary cancer                                          76
  Benign ampullary tumor                                    6
  Duodenal stromal tumor                                    7
  Duodenal cancer                                           10
  Chronic mucosal inflammation of the descending duodenum   3
  Duodenal papillary cancer                                 90
  Benign duodenal papillary tumor                           6
  Duodenal papillary neuroendocrine tumor                   3
  Total                                                     539

Univariate analysis
-------------------

Univariate analysis showed no significant correlation between POPF and the following factors: age, hypertension, alcohol consumption, smoking, history of upper abdominal surgery, preoperative jaundice management, preoperative bilirubin, preoperative albumin, pancreatic duct drainage, intraoperative blood loss, operative time, intraoperative blood transfusion, Braun anastomosis, and pancreaticoduodenectomy (with or without pylorus preservation). Conversely, a significant correlation was observed between POPF and the following factors: gender (male *vs* female: 54.23% *vs* 42.35%, *P* = 0.008), diabetes (non-diabetic *vs* diabetic: 51.61% *vs* 39.19%, *P* = 0.047), BMI (≤ 25 *vs \>* 25: 46.94% *vs* 57.82%, *P* = 0.024), blood glucose level (≤ 6.0 mmol/L *vs \>* 6.0 mmol/L: 54.75% *vs* 41.14%, *P* = 0.002), pancreaticojejunal anastomosis technique (pancreatic duct-jejunum double-layer mucosa-to-mucosa pancreaticojejunal anastomosis *vs* pancreatic-jejunum single-layer mucosa-to-mucosa anastomosis: 57.54% *vs* 35.46%, *P* = 0.000), diameter of the pancreatic duct (≤ 3 mm *vs \>* 3 mm: 57.81% *vs* 38.36%, *P* = 0.000), and pancreatic texture (soft *vs* hard: 56.72% *vs* 29.93%, *P* = 0.000) (Table [3](#T3){ref-type="table"}).

###### 

Risk factors for pancreatic fistula according to univariate analysis

  Variable                                POPF occurrence                  
  --------------------------------------- ----------------- ----- -------- -------
  Sex                                                             7.042    0.008
  Male                                    186               157            
  Female                                  83                113            
  Age (yr)                                                        2.132    0.144
  ≥ 60                                    99                116            
  \< 60                                   170               154            
  Body mass index (kg/m^2^)                                       5.066    0.024
  \> 25                                   85                62             
  ≤ 25                                    184               208            
  Hypertension                                                    0.938    0.332
  Yes                                     62                53             
  No                                      207               217            
  Diabetes mellitus                                               3.941    0.047
  Yes                                     29                45             
  No                                      240               225            
  Drinking history                                                0.169    0.681
  Yes                                     77                73             
  No                                      193               197            
  Smoking history                                                 1.426    0.232
  Yes                                     78                66             
  No                                      191               204            
  Epigastrium surgery                                             0.640    0.424
  Yes                                     18                23             
  No                                      251               247            
  Preoperative biliary drainage                                   0.406    0.524
  Yes                                     65                59             
  No                                      204               211            
  Preoperative total bilirubin (μmol/L)                           0.378    0.539
  \> 171                                  73                67             
  ≤ 171                                   196               203            
  Serum albumin (g/L)                                             0.000    0.985
  \< 35                                   41                41             
  ≥ 35                                    228               229            
  Blood glucose (mmol/L)                                          9.157    0.002
  ≤ 6.0                                   190               157            
  \> 6.0                                  79                113            
  Pancreaticojejunostomy                                          20.323   0.000
  Double-layer mucosa-to-mucosa           229               169            
  Single-layer mucosa-to-mucosa           50                91             
  Blood loss (mL)                                                 0.134    0.715
  \> 600                                  34                37             
  ≤ 600                                   235               225            
  Pancreatic duct diameter (mm)                                   19.687   0.000
  ≤ 3                                     185               135            
  \> 3                                    84                135            
  Pylorus-preserving                                              0.017    0.897
  Yes                                     131               133            
  No                                      138               137            
  Pancreatic duct drainage                                        0.016    0.900
  External                                64                63             
  Enteral                                 205               207            
  Intraoperative blood infusion                                   1.310    0.252
  Yes                                     36                46             
  No                                      233               224            
  Operative time (min)                                            0.299    0.584
  \> 300                                  196               191            
  ≤ 300                                   73                79             
  Braun anastomosis                                               2.274    0.132
  Yes                                     78                94             
  No                                      192               175            
  Pancreatic texture                                              29.330   0.000
  Soft                                    228               174            
  Hard                                    41                96             

Multivariate logistic regression analysis
-----------------------------------------

The risk factors for pancreatic fistula (gender, diabetes, BMI, blood glucose level, pancreaticojejunal anastomosis technique, the diameter of the pancreatic duct, and pancreatic texture) demonstrated in the univariate analysis were incorporated into the logistic regression analysis. The results showed that gender (male), BMI \> 25, pancreatic duct-jejunum double-layer mucosa-to-mucosa pancreaticojejunal anastomosis, pancreatic duct diameter ≤ 3 mm, and soft pancreas were risk factors for pancreatic fistula after pancreaticoduodenectomy (Table [4](#T4){ref-type="table"}).

###### 

Logistic regression for the predictors of pancreatic fistula following pancreaticoduodenectomy

  Variable                   B       SE      Wals     *P* value   OR      95%CI
  -------------------------- ------- ------- -------- ----------- ------- -------------
  Sex                        0.579   0.196   8.688    0.003       1.784   1.214-2.622
  Body mass index            0.518   0.213   5.941    0.015       1.679   1.107-2.546
  Pancreaticojejunostomy     0.743   0.217   11.723   0.001       2.102   1.374-3.216
  Pancreatic duct diameter   0.724   0.192   14.254   0.000       2.062   1.416-3.003
  Pancreatic texture         1.115   0.227   24.102   0.000       3.048   1.953-4.757

DISCUSSION
==========

The causes of pancreatic fistula include pancreaticojejunal anastomotic leak, leak from pancreatic resection, leak associated with damage to the pancreatic capsule, and leak *via* the puncture channel. Pancreatic fistula after pancreaticoduodenectomy is a common and serious complication and the most important cause of subsequent complications and death after this procedure\[[@B8],[@B24]-[@B26]\]. The dilemma of pancreatic fistula after pancreaticoduodenectomy has not yet been resolved\[[@B27]\]. Currently, researchers believe that the following factors are related to pancreatic fistula: gender, age, preoperative jaundice, intraoperative blood loss, operative time, pancreatic texture, BMI, diameter of the main pancreatic duct, and pancreaticojejunal anastomosis\[[@B14],[@B28]-[@B32]\]. Peng et al\[[@B33]\] suggested that bundled pancreaticogastrostomy was a safe and effective anastomosis technique to prevent the leakage of pancreatic juice from pancreaticojejunal anastomosis. Shubert *et al*\[[@B34]\] believed that the clinical risk score for pancreatic fistula (CRS-PF) could effectively predict pancreatic fistula after pancreaticoduodenectomy. In this study, multivariate logistic regression analysis showed that gender (male), BMI \> 25, pancreatic duct-jejunum double-layer mucosa-to-mucosa pancreaticojejunal anastomosis, pancreatic duct diameter ≤ 3 mm, and soft pancreas were risk factors for pancreatic fistula after pancreaticoduodenectomy.

Kawai retrospectively analyzed the perioperative data from 1239 patients treated at 11 medical facilities from 2005 to 2009 and summarized that the male gender was a risk factor for pancreatic fistula after pancreaticoduodenectomy\[[@B35]\]. This study included 343 male patients (POPF rate: 54.23%) and 196 female patients (POPF rate: 42.35%). Univariate analysis showed that the difference in the POPF rate was significant (*P* = 0.008), suggesting that male patients were at a higher risk than female patients for the development of pancreatic fistula after pancreaticoduodenectomy. Additionally, multivariate logistic regression analysis showed that the difference was significant (*P* = 0.003), suggesting that gender (male) was a risk factor for pancreatic fistula after pancreaticoduodenectomy. The odds ratio (OR = 1.784; 95%CI: 1.214-2.622) showed that the risk of developing pancreatic fistula after pancreaticoduodenectomy was 1.784-fold higher in male patients than in female patients.

El Nakeeb et al\[[@B36]\] analyzed 471 cases of pancreaticoduodenectomy and found that BMI \> 25 was a risk factor for POPF. Gaujoux et al\[[@B28]\] analyzed 100 successive cases of pancreaticoduodenectomy and similarly found that BMI \> 25 was a risk factor for pancreatic fistula after pancreaticoduodenectomy. In our study, 392 patients had a BMI ≤ 25 (POPF rate: 46.94%), and 147 patients had a BMI \> 25 (POPF rate: 57.82%). Univariate analysis showed that the difference in the POPF rates was significant (*P* = 0.024), suggesting that patients with a BMI \> 25 were at a higher risk of developing pancreatic fistula after pancreaticoduodenectomy than patients with a BMI ≤ 25. Additionally, multivariate logistic regression analysis showed that the difference was significant (*P* = 0.015 \< 0.05), which indicated that BMI \> 25 was a risk factor for pancreatic fistula after pancreaticoduodenectomy. The OR (1.679, 95%CI: 1.107-2.546) showed that the risk of developing a pancreatic fistula after pancreaticoduodenectomy was 1.679-fold higher in patients with a BMI \> 25 than in patients with a BMI ≤ 25. The higher incidence of pancreatic fistula after pancreaticoduodenectomy in patients with a BMI \> 25 may be associated with the following factors: increased difficulty in exposing the pancreas during surgery due to a higher volume of abdominal fat and peripancreatic fat, a higher risk of damage to the pancreatic capsule during separation due to a soft and brittle pancreas, and a higher risk of pancreatic leakage caused by damage to the pancreatic tissue and fine pancreatic ducts due to suturing and knotting during pancreaticojejunal anastomosis.

Pancreaticojejunal anastomosis is a critical step during pancreaticoduodenectomy and affects the surgical outcome. However, pancreaticojejunal anastomosis is a complex procedure during pancreaticoduodenectomy, and the choice of an appropriate pancreaticojejunal anastomosis technique should reduce the incidence of pancreatic fistula\[[@B33],[@B37]-[@B40]\]. Fu et al\[[@B32]\] retrospectively analyzed 532 cases of pancreaticoduodenectomy and found that the pancreaticojejunal anastomosis technique was a risk factor for pancreatic fistula after pancreaticoduodenectomy. In this study, pancreatic duct-jejunum double-layer mucosa-to-mucosa pancreaticojejunal anastomosis was performed in 398 patients (POPF rate: 57.54%), and pancreatic-jejunum single-layer mucosa-to-mucosa anastomosis was performed in 141 patients (POPF rate: 35.46%). Univariate analysis showed that the difference in the POPF rates was significant (*P* = 0.000), suggesting that patients who underwent pancreatic duct-jejunum double-layer mucosa-to-mucosa pancreaticojejunal anastomosis were at a higher risk of developing pancreatic fistula after pancreaticoduodenectomy than patients who underwent pancreatic-jejunum single-layer mucosa-to-mucosa anastomosis. Additionally, multivariate logistic regression analysis showed that the difference was significant (*P* = 0.001), suggesting that pancreatic duct-jejunum double-layer mucosa-to-mucosa pancreaticojejunal anastomosis was an independent risk factor for pancreatic fistula after pancreaticoduodenectomy. The OR (2.102, 95%CI: 1.374-3.216) indicated that the risk of developing a pancreatic fistula after pancreaticoduodenectomy was 2.102-fold higher in patients who underwent pancreatic duct-jejunum double-layer mucosa-to-mucosa pancreaticojejunal anastomosis than in patients who underwent pancreatic-jejunum single-layer mucosa-to-mucosa anastomosis. The higher incidence of pancreatic fistula after pancreaticoduodenectomy in patients who underwent pancreatic duct-jejunum double-layer mucosa-to-mucosa pancreaticojejunal anastomosis may be related to the following factors: use of the 6-0 PDS II suture during pancreatic duct-jejunum anastomosis because the fine suture can easily cut the pancreatic duct during suturing and knotting, thereby resulting in a pancreaticojejunal anastomotic leak, and the use of the 5-0 PDS II suture to suture the pancreatic section and the jejunal seromuscular layer because this suture can easily cut the pancreas and fine pancreatic ducts during suturing and may not tightly secure the pancreatic section and the jejunal seromuscular layer, thereby resulting in pancreatic leakage and leakage from the fine pancreatic ducts. In contrast, the 4-0 Vicryl suture is used for full-layer suturing of the pancreas, the pancreatic duct, and the jejunum during pancreatic-jejunum single-layer mucosa-to-mucosa anastomosis; therefore, the suture is secure and reduces the risk of cutting the pancreas. Moreover, the jejunal seromuscular layer covers the entire pancreatic section and presses the fine pancreatic ducts at the pancreatic section, thereby reducing pancreatic leakage\[[@B38]\].

A soft pancreas is a risk factor for pancreatic fistula after pancreaticoduodenectomy\[[@B35]-[@B37],[@B41],[@B42]\]. The pancreatic stumps of all cases were submitted for pathological diagnosis of the degree of pancreatic fibrosis. All cases of pancreatic texture were divided into two groups (normal soft pancreas with no significant fibrosis, as shown in Figure [1A](#F1){ref-type="fig"}, and hard pancreas with fibrosis, as shown in Figure [1B](#F1){ref-type="fig"}). In this study, 402 patients had a soft pancreas (POPF rate: 56.72%), and 137 patients had a hard pancreas (POPF rate: 29.93%). Univariate analysis showed that the difference in the POPF rates was significant (*P* = 0.000), suggesting that patients with a soft pancreas were at a higher risk of developing a pancreatic fistula after pancreaticoduodenectomy than patients with a hard pancreas. Additionally, multivariate logistic regression analysis demonstrated that the difference was significant (*P* = 0.000), which indicated that a soft pancreas was an independent risk factor for pancreatic fistula after pancreaticoduodenectomy. The OR (3.048, 95%CI: 1.953-4.757) showed that the risk of developing a pancreatic fistula after pancreaticoduodenectomy was 3.048-fold higher in patients with a soft pancreas than in patients with a hard pancreas. The higher incidence of pancreatic fistula after pancreaticoduodenectomy in patients with a soft pancreas may be related to insecure suturing and knotting, which can result in unsatisfactory pancreaticojejunal anastomosis and a higher risk of damage to the pancreatic tissue and fine pancreatic ducts during suturing and knotting of a soft pancreas, resulting in pancreatic leakage. The lower incidence of pancreatic fistula after pancreaticoduodenectomy in patients with a hard pancreas may be related to pancreatic exocrine dysfunction due to prolonged pancreatic duct obstruction and pancreatic fibrosis, secure pancreaticojejunal anastomosis, and obstructed minor ducts at the cut-surface of the hard pancreas, and this could help reduce POPF\[[@B43]\] and risk of damage to the pancreatic tissue and fine pancreatic ducts during suturing and knotting. Pancreatic texture is the most significant single predictor of POPF, and clinicians should select a pancreaticojejunal anastomosis technique based on the texture of the pancreas to reduce the incidence of POPF\[[@B44]\].

![Photomicrographs of the pathological examination for pancreatic fibrosis. A: No significant fibrosis; B: Severe fibrosis (hematoxylin-eosin staining; original magnification, × 100).](WJG-22-7797-g001){#F1}

Pancreatic duct diameter ≤ 3 mm is a risk factor for pancreatic fistula after pancreaticoduodenectomy\[[@B14],[@B37]\]. In this study, the diameter of the pancreatic duct was ≤ 3 mm in 320 patients (POPF rate: 57.81%) and \> 3 mm in 219 patients (POPF rate: 38.36%). Univariate analysis showed that the difference in the POPF rates was significant (*P* = 0.000), suggesting that patients with a pancreatic duct diameter ≤ 3 mm were at a higher risk of developing a pancreatic fistula after pancreaticoduodenectomy than patients with a pancreatic duct diameter \> 3 mm. Additionally, multivariate logistic regression analysis indicated that the difference was significant (*P* = 0.000), suggesting that pancreatic duct diameter ≤ 3 mm was an independent risk factor for pancreatic fistula after pancreaticoduodenectomy. The OR (2.062, 95%CI: 1.416-3.003) showed that the risk of developing a pancreatic fistula after pancreaticoduodenectomy was 2.062-fold higher in patients with a pancreatic duct diameter ≤ 3 mm than in patients with a pancreatic duct diameter \> 3 mm. The lower incidence of pancreatic fistula after pancreaticoduodenectomy in patients with a pancreatic duct diameter \> 3 mm may be related to pancreatic duct obstruction, pancreatic duct fibrosis, pancreatic fibrosis, ease of suturing, and a lower risk of damage to the pancreatic duct during suturing and knotting. As a result, the incidence of pancreatic fistula after pancreaticoduodenectomy was lower in patients with pancreatic duct dilation than in patients without.

Univariate analysis demonstrated that the incidence of pancreatic fistula after pancreaticoduodenectomy was significantly lower in diabetic patients than in non-diabetic patients (39.19% *vs* 51.61%, *P* = 0.047) and was significantly lower in patients with a blood glucose level \> 6.0 mmol/L than in patients with a blood glucose level ≤ 6.0 mmol/L (41.14% *vs* 54.75%, *P* = 0.002). However, multivariate logistic regression analysis showed that these differences were not significant (*P* = 0.268 and *P* = 0.115, respectively); therefore, diabetes was not a risk factor for POPF.

In conclusion, gender (male), BMI \> 25, pancreatic duct-jejunum double-layer mucosa-to-mucosa pancreaticojejunal anastomosis, pancreatic duct diameter ≤ 3 mm, and soft pancreas were risk factors for pancreatic fistula after pancreaticoduodenectomy.

COMMENTS
========

Background
----------

Pancreaticoduodenectomy remains the standard surgical treatment for tumors involving the lower bile duct, the pancreatic head, the duodenal papilla, and the ampulla. Pancreaticoduodenectomy is difficult to perform and is associated with high morbidity and mortality. Most complications after pancreaticoduodenectomy are associated with postoperative pancreatic fistula (POPF); however, no definitive approach can prevent pancreatic fistulas.

Research frontiers
------------------

The incidence of tumors involving the lower bile duct, the pancreatic head, the duodenal papilla, and the ampulla increases each year, and more patients are undergoing pancreaticoduodenectomy. Surgical techniques and perioperative management are improving; however, the incidence and postoperative mortality of POPF remain high.

Innovations and breakthroughs
-----------------------------

Gender (male), BMI \> 25, pancreatic duct-jejunum double-layer mucosa-to-mucosa pancreaticojejunal anastomosis, pancreatic duct diameter ≤ 3 mm, and soft pancreas are risk factors for pancreatic fistula after pancreaticoduodenectomy. Postoperative complications and deaths are related to pancreatic fistulas. For patients with a small pancreatic duct diameter or a soft pancreas, surgeons should select a pancreaticojejunal anastomosis technique that is associated with a lower incidence of POPF.

Applications
------------

POPF was diagnosed in strict accordance with the definition of pancreatic fistula from the ISGPF. POPFs are more common in patients with relevant risk factors, such as male gender, BMI \> 25, pancreatic duct-jejunum double-layer mucosa-to-mucosa pancreaticojejunal anastomosis, pancreatic duct diameter ≤ 3 mm, and soft pancreas. Care must be taken in patients with any of these risk factors, and an appropriate pancreaticojejunal anastomosis technique should be selected based on the texture of the pancreas and the diameter of the pancreatic duct. Patients must be closely monitored after surgery, and patients with a pancreatic fistula must be treated promptly to reduce the risk of fatal complications.

Terminology
-----------

Pancreaticoduodenectomy remains the standard surgical treatment for tumors involving the lower bile duct, the pancreatic head, the duodenal papilla, and the ampulla. POPF is common after pancreaticoduodenectomy and is the leading cause of postoperative complications and death following this procedure.

Peer-review
-----------

This retrospective study was well designed, and the statistical analysis was highly accurate. The article has a sufficient number of references. The manuscript language is of high quality, and the conclusions of the study are rational. The findings from this study contribute to our understanding of pancreatic fistula after pancreaticoduodenectomy. Readers with an interest in pancreatic fistulas will find this paper beneficial and informative.
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